Skip to main navigation Skip to search Skip to main content

Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women.

  • Robert J. Zeglin
  • , Juliet L Fetteroll
  • University of North Florida

Research output: Contribution to journalArticlepeer-review

Abstract

Nearly all cases of cervical cancer are attributable to human papillomavirus (HPV), making it a significant women's health issue. Though there have been advances in the prevention of HPV via vaccination, significant barriers continue to suppress vaccination rates for girls.
Original languageAmerican English
Pages (from-to)976-981
JournalInternational Journal of Std & Aids
Volume31
Issue number10
DOIs
StatePublished - Jul 21 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 5 - Gender Equality
    SDG 5 Gender Equality

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Fingerprint

Dive into the research topics of 'Human papillomavirus vaccine timing associated with eventual human papillomavirus diagnosis in women.'. Together they form a unique fingerprint.

Cite this